NASM CPT, CES & PES; NSCA CSCS; ACE-CPT & HC; ACSM EP-C; USAW1; CISSN

SDSU and NASM faculty, and scientific advisor for OrangeTheory, Core Health and Fitness, and Caloric Responsibility. Previously, with ACE, he was the original creator of ACE’s IFT™ model and their live educational workshops. Prior experiences include Division I collegiate head coach and strength-conditioning coach; opening/managing clubs for Club One, and president of Genesis Wellness Consulting. He is a national and international presenter; media spokesperson and accomplished author.

Michael Joyce holds a PhD. in Biochemistry From the University of Alberta. Originally a biochemist and enzymologist, Michael Joyce has been working in viral immunology and liver disease for the past 18 years.

His training in structure and function of the key enzyme in the TCA cycle , succinyl-CoA synthetase which has specialized isoforms in liver tissue, left him well prepared to examine the pathology of liver disease. He has played key roles in the development and use of the first small animal model suitable for HCV infection and replication. His studies on oxidative and the unfolded protein response induced by the twin pressures of viral infection and inflammation have led to the current development of an in vitro model for liver disease. In parallel he has examined the innate immune response to HCV and these considerations have led to the discovery that HCV and many other viruses hijack the Nuclear pore complex to their replication complexes in order to evade intracellular innate immune responses.

Further interests include developing a method for differentiating hepatoma cells into hepatocyte–like cells which establish tight junctions, become contact inhibited and preform complex hepatocyte specific tasks like secreting VLDL; the only cell-line which does this. The differentiation process changes the expression of an astonishing 1/3 of the genes. These cells are currently being commercialized for use in liver toxicity and other applications in partnership with commercial interests.

We are honouring Dr. Charles S. Lieber’s life time work of study and the advancement of PPC and the treatment of alcoholism.

Feb. 13, 1931 to March 1, 2009

Dr. Lieber devoted much of his career to advancing the understanding of the pathogenesis of alcohol liver disease and, consequently potential therapies to treat this chronic condition. Lieber was born in Antwerp, Belgium, on Feb. 13, 1931. He earned his medical degree in 1955 at the University of Brussels “He was a giant in his field, probably the most eminent in the world in alcohol and the liver,” said Dr. Steven Schenker, another expert, at the University of Texas Health Science Center at San Antonio. He was 78 and lived in Englewood Cliffs, N.J when he passed away after battling stomach cancer.

Thomas Lee Abshier, ND practices as a Naturopathic Physician in Portland Oregon where he has maintained a general family practice including internal medicine and counselling for the past 20 years.

Dr. Abshier graduated from National College of Naturopathic Medicine in 1987 after pursuing a wide range of life and educational experiences including: a Bachelor of Science from the UCLA School of Engineering, Naval Nuclear Power School, submarine service as a US Naval officer, and various consulting and management positions before pursuing his career in Naturopathic Medicine.

“It is not hyperbole to write that there are few scientists who have done as much to advance the health of those infected with hepatitis B virus as Dr. Tyrrell,” Dr. Timothy Block, president of the Hepatitis B Foundation at the Pennsylvania Institute for Hepatitis and Virus Research

Dr. Lorne Tyrrell has helped shape policy in education, health care, and health research. He is the current CIHR/GlaxoSmithKline Chair in Virology at the University of Alberta and the Chief Scientific Officer of KMT, a biotechnology company in Edmonton. Dr. Tyrrell is the Chair of the Board of the Health Quality Council of Alberta, Chair of the Board of the Institute of Health Economics, a Board Member of the Gairdner Foundation.

Peter Schmid, Peter Schmid, M.D. also holds a degree in engineering from the Federal Engineering Institute, Austria.

Before he moved to the United States, where he held a position as assistant Professor at the University of Vienna Hospital, Internal Medicine and Surgery Departments, he made a variety of medical technical inventions and conducted/published research mainly in the field of metabolism and nutrition. At this time Dr. Schmid also became a certified specialist in Internal Medicine.